EcoDrugPlus

Ensembl ID : ENSCVAG00000002108
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSCVAG00000000685
Gene Symbol: -
Cross references: -
252 Possible Orthologues:

Ensembl ID : ENSCVAG00000021387
Gene Symbol: -
1 Cross references
254 Possible Orthologues:

Ensembl ID : ENSCVAG00000022379
Gene Symbol: -
Cross references: -
141 Possible Orthologues:

Ensembl ID : ENSCVAG00000022049
Gene Symbol: -
Cross references: -
168 Possible Orthologues:

Ensembl ID : ENSCVAG00000014955
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSCVAG00000015029
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSCVAG00000002902
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSCVAG00000019922
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSCVAG00000015117
Gene Symbol: -
Cross references: -
390 Possible Orthologues:

Ensembl ID : ENSCVAG00000015125
Gene Symbol: -
Cross references: -
389 Possible Orthologues:

Ensembl ID : ENSCVAG00000002915
Gene Symbol: -
Cross references: -
232 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).